56 related articles for article (PubMed ID: 2134562)
1. Continuous v intermittent cimetidine infusion in critically ill hospitalized patients: role of TPN admixture as drug vehicle.
Driscoll DF; Lowell JA; Nompleggi D; Manji N; Lewis D; Bistrian BR
Nutrition; 1990; 6(5):383-8. PubMed ID: 2134562
[TBL] [Abstract][Full Text] [Related]
2. Cimetidine and parenteral nutrition in the ICU patient.
Baptista RJ
Clin Ther; 1986; 8 Suppl A():34-8. PubMed ID: 3098428
[TBL] [Abstract][Full Text] [Related]
3. [Total parenteral nutrition in critical patients. The metabolic-nutritional aspects and effects on immune function of 2 different isocaloric-isonitrogenous regimens].
Da Pont MC; Pezzana A; Demagistris A; Balzola F; Cassader M; Boggio Bertinet D; Balzola F
Minerva Gastroenterol Dietol; 1994 Mar; 40(1):17-26. PubMed ID: 8204701
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of two cimetidine regimens on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer.
Mahachai V; Walker K; Jamali F; Navert H; Cook D; Symes A; Thomson AB
Clin Ther; 1984; 6(3):259-81. PubMed ID: 6373006
[TBL] [Abstract][Full Text] [Related]
5. Stability of cimetidine hydrochloride in a total nutrient admixture.
Baptista RJ; Palombo JD; Tahan SR; Valicenti AJ; Bistrian BR; Arkin CF; Blackburn GL
Am J Hosp Pharm; 1985 Oct; 42(10):2208-10. PubMed ID: 3933337
[TBL] [Abstract][Full Text] [Related]
6. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill.
More DG; Raper RF; Munro IA; Watson CJ; Boutagy JS; Shenfield GM
Surgery; 1985 Feb; 97(2):215-24. PubMed ID: 3881838
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of duodenal ulcer with cimetidine. Intermittent or continuous therapy?
Hetzel DJ; Hecker R; Shearman DJ
Med J Aust; 1980 Nov; 2(11):612-4. PubMed ID: 7007840
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients; a double blind randomized controlled trial.
Lindgren BF; Ruokonen E; Magnusson-Borg K; Takala J
Clin Nutr; 2001 Feb; 20(1):43-8. PubMed ID: 11161543
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.
Rafati MR; Rouini MR; Mojtahedzadeh M; Najafi A; Tavakoli H; Gholami K; Fazeli MR
Int J Antimicrob Agents; 2006 Aug; 28(2):122-7. PubMed ID: 16815689
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
12. Lethality of standard total parenteral nutrition following major liver resection in rats is prevented by high arginine and high branched chain amino acids but not by glutamine.
Qiu JG; Delany HM; Teh EL; Gliedman ML; Chang CJ; Levenson SM
J Assoc Acad Minor Phys; 2001 Mar; 12(1-2):109-18. PubMed ID: 11851195
[TBL] [Abstract][Full Text] [Related]
13. The effect of abrupt cessation of total parenteral nutrition on serum glucose: a randomized trial.
Nirula R; Yamada K; Waxman K
Am Surg; 2000 Sep; 66(9):866-9. PubMed ID: 10993619
[TBL] [Abstract][Full Text] [Related]
14. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of increasing dosages of glycyl-glutamine for total parenteral nutrition in polytrauma patients.
Weingartmann G; Fridrich P; Mauritz W; Götzinger P; Mittlböck M; Germann P; Karner J; Roth E
Wien Klin Wochenschr; 1996; 108(21):683-8. PubMed ID: 8956477
[TBL] [Abstract][Full Text] [Related]
16. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
17. Cimetidine pharmacokinetics after oral administration of cimetidine retard in normal and impaired renal function.
Shaheen RA; Zazgornik J; Kuska J; Kokot F; Schneider J
Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):480-6. PubMed ID: 2272709
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
20. Providing 24-hour nutrient infusions to critically ill patients.
Mirtallo JM; Jozefczyk KG; Hale KM; Grauer DW; Ebbert ML; Fabri PJ
Am J Hosp Pharm; 1986 Sep; 43(9):2205-8. PubMed ID: 3094371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
